Loading the player...
Information
Non-Surgical, Non-Narcotic Treatment of Lower Back Pain
Length: 52:22
First presented at the Florida Osteopathic Medical Association 2023 virtual Seminar. FOMA is proud to offer this on-demand CME program as Daniel Kassicieh, DO shares his expertise on how to reduce lower back pain without surgery.
Learning Objectives:
1. Appreciate that there are new interventional treatments for low back pain that are becoming more widely available in 2022
2. Learn about the rationale for using intra-discal therapies and associated published studies and randomized controlled trial data
3. Learn about basivertebral nerve ablation and randomized clinical trial data
4. Recognize the need for additional studies for new treatments and clinical research participation in our practices
Dr. Kassicieh, DO has no actual or potential conflict of interest in relation to this program or presentation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL 32301, or by email to admin@foma.org
Daniel Kassicieh, DO, FAAN, FACN
Daniel Kassicieh, DO, FAAN, FACN, is a dual-board certified neurologist and is the medical director of the Florida Headache Center. He has been practicing Headache Medication in Sarasota for over 25 years. Dr. Kassicieh is a Fellow in both the American Academy of Neurology and American College of Neuropsychiatrists. Both of these honors were awarded to him on the basis of his extensive research experience, medical publications and continued support of headache/migraine patients and their families who are affected with neurological disorders. He was the founder and medical director of Neurological Research Institute of Sarasota. NRIS specialized in doing Phase 3B studies, including triptans and Botox treatment for migraine. Dr. Kassicieh’s primary medical interests are in the treatment of migraine and other headache disorders. He has lectured extensively on diagnosis, treatment and management of patients suffering from migraines and chronic headache disorders.
